Moderna IncNASDAQ:MRNA
- LAST PRICE62.1800
- TODAY'S CHANGE (%)-0.9800 (-1.5516%)
- Bid / Lots62.1700/ 1
- Ask / Lots62.2100/ 1
- Open / Previous Close62.5300 / 63.1600
- Day Range
- 52 Week Range
- Volume1,935,615
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MRNA |
|---|---|---|
| 09:32 ET | 79691 | 62.82 |
| 09:34 ET | 14133 | 62.81 |
| 09:36 ET | 65494 | 62.53 |
| 09:38 ET | 25485 | 62.735 |
| 09:39 ET | 11774 | 62.425 |
| 09:41 ET | 8954 | 62.376 |
| 09:43 ET | 6655 | 62.5675 |
| 09:45 ET | 9970 | 62.47 |
| 09:48 ET | 23587 | 62.4462 |
| 09:50 ET | 24120 | 62.394 |
| 09:52 ET | 33742 | 62.16 |
| 09:54 ET | 27530 | 62.1301 |
| 09:56 ET | 29049 | 62.21 |
| 09:57 ET | 18119 | 62.33 |
| 09:59 ET | 5637 | 62.3399 |
| 10:01 ET | 22931 | 62.5 |
| 10:03 ET | 20619 | 62.395 |
| 10:06 ET | 9350 | 62.3825 |
| 10:08 ET | 14102 | 62.2601 |
| 10:10 ET | 8297 | 62.32 |
| 10:12 ET | 11196 | 62.325 |
| 10:14 ET | 9868 | 62.29 |
| 10:15 ET | 114344 | 62.09 |
| 10:17 ET | 7462 | 62.23 |
| 10:19 ET | 8560 | 62.18 |
| 10:21 ET | 7618 | 62.195 |
| 10:24 ET | 38438 | 61.82 |
| 10:26 ET | 21249 | 61.84 |
| 10:28 ET | 17213 | 61.82 |
| 10:30 ET | 10579 | 61.97 |
| 10:32 ET | 26194 | 61.7239 |
| 10:33 ET | 24980 | 61.885 |
| 10:35 ET | 8484 | 62.0586 |
| 10:37 ET | 6938 | 61.865 |
| 10:39 ET | 8785 | 61.97 |
| 10:42 ET | 7146 | 61.9 |
| 10:44 ET | 15396 | 61.78 |
| 10:46 ET | 16655 | 61.8699 |
| 10:48 ET | 12195 | 61.92 |
| 10:50 ET | 11297 | 61.86 |
| 10:51 ET | 7555 | 61.9 |
| 10:53 ET | 13929 | 61.815 |
| 10:55 ET | 16608 | 61.86 |
| 10:57 ET | 11140 | 61.85 |
| 11:00 ET | 11567 | 61.8 |
| 11:02 ET | 22936 | 61.755 |
| 11:04 ET | 10128 | 61.78 |
| 11:06 ET | 21152 | 61.67 |
| 11:08 ET | 20657 | 61.77 |
| 11:09 ET | 8703 | 61.8164 |
| 11:11 ET | 11023 | 61.82 |
| 11:13 ET | 5378 | 61.805 |
| 11:15 ET | 5706 | 61.78 |
| 11:18 ET | 22077 | 61.845 |
| 11:20 ET | 55594 | 61.6523 |
| 11:22 ET | 17172 | 61.635 |
| 11:24 ET | 10631 | 61.7401 |
| 11:26 ET | 10404 | 61.8 |
| 11:27 ET | 5558 | 61.795 |
| 11:29 ET | 3849 | 61.76 |
| 11:31 ET | 7812 | 61.8999 |
| 11:33 ET | 8566 | 61.89 |
| 11:36 ET | 6069 | 61.84 |
| 11:38 ET | 6625 | 61.9 |
| 11:40 ET | 6197 | 61.835 |
| 11:42 ET | 9356 | 61.8 |
| 11:44 ET | 16876 | 61.79 |
| 11:45 ET | 5518 | 61.815 |
| 11:47 ET | 4846 | 61.9 |
| 11:49 ET | 8723 | 61.83 |
| 11:51 ET | 8532 | 61.95 |
| 11:54 ET | 14531 | 62.092 |
| 11:56 ET | 16407 | 62.11 |
| 11:58 ET | 10920 | 62.062 |
| 12:00 ET | 4391 | 62.035 |
| 12:02 ET | 6644 | 62.06 |
| 12:03 ET | 6227 | 62.015 |
| 12:05 ET | 13576 | 61.8825 |
| 12:07 ET | 9840 | 61.885 |
| 12:09 ET | 9677 | 61.93 |
| 12:12 ET | 21586 | 62.14 |
| 12:14 ET | 39793 | 62.055 |
| 12:16 ET | 8836 | 62.075 |
| 12:18 ET | 13460 | 62.08 |
| 12:20 ET | 19346 | 62 |
| 12:21 ET | 7332 | 62.09 |
| 12:23 ET | 11312 | 62.18 |
Today
Moderna Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Reach Out To The Schall Law Firm, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNA, from 2 hours ago by Dow Jones
2 hours ago by Dow JonesSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNA, from 2 hours ago by Dow Jones
2 hours ago by Dow JonesInvaio Sciences Appoints Andr Andonian as Chairman of the Board of Directors, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesPress Release: Invaio Sciences Appoints Andr Andonian as Chairman of the Board of Directors, from 4 hours ago by Dow Jones
4 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Moderna Inc | 24.3B | -4.0x | --- |
ICON PLC | 24.4B | 34.2x | +4.68% |
Biontech SE | 28.3B | -51.5x | --- |
Biogen Inc | 27.5B | 23.4x | -18.14% |
Grifols SA | 7.1B | 36.4x | --- |
Beigene Ltd | 26.3B | -46.1x | --- |
Company Information
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Contact Information
- Headquarters
- 325 BINNEY STREETCambridge, MA, United States 02142
- Phone
- 617-714-6500
- Fax
- 617-583-1998
Executives
- Non-Executive Independent Chairman of the Board, Co-Founder
- Noubar Afeyan
- President
- Stephen Hoge
- Chief Executive Officer, Director
- Stephane Bancel
- Chief Financial Officer
- James Mock
- Chief Technical Operations and Quality Officer
- Jerh Collins
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $24.3B |
|---|---|
Revenue (TTM) | $5.1B |
Shares Outstanding | 384.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.67 |
EPS | $-15.37 |
Book Value | $36.27 |
P/E Ratio | -4.0x |
Price/Sales (TTM) | 4.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -91.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
